Clinical Trials Logo
  1. Home
  2. Bleeding Disorder
  3. NCT05713734

Bleeding of Unknown Cause: a Swiss Case-control Study — SWISS-BUC  

Bleeding Disorder Clinical Trial

Official title:
Bleeding of Unknown Cause, Insight Into a Multifactorial Bleeding Disorder: a Swiss Case-control Study

Clinical Trial Summary

The goal of this prospective cohort is to identified specific biological patterns in patients with a bleeding of unknown cause and to study the specific mechanisms of the bleeding disorder for each subset of patients.

Clinical Trial Description

Patients with bleeding of unknown cause are included. At baseline, blood will be drawn to evaluate the hemostatic profile. Findings are compared to a control group of healthy individuals. Patients and controls are followed for 3 years. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05713734
Study type Observational
Source University Hospital, Geneva
Contact Alessandro Casini
Phone 0041223729757
Email alessandro.casini@hcuge.ch
Status Recruiting
Phase
Start date April 1, 2023
Completion date April 1, 2027
View Details
See also
  Status Clinical Trial Phase
Completed NCT03834727 - Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders
Recruiting NCT04398628 - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Completed NCT00772434 - Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument N/A
Completed NCT03871452 - The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding N/A
Recruiting NCT03095625 - Role of Thromboelastography in Septic Shock N/A
Recruiting NCT04600609 - Examining the Experiences of Children With Blood Disorders
Completed NCT02979158 - Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass N/A
Active, not recruiting NCT04912336 - Extracorporeal Life Support and Modification of Hemostasis
Terminated NCT05790109 - Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures. N/A
Not yet recruiting NCT05916469 - Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Recruiting NCT06250595 - European Rare Blood Disorders Platform (ENROL)
Not yet recruiting NCT06118372 - Recombinant vWF Concentrate and ECMO Phase 1
Completed NCT03355742 - XIENCE 28 Global Study N/A
Completed NCT03815175 - XIENCE 28 USA Study N/A
Completed NCT03444324 - Adjusted Fibrinogen Replacement Strategy Phase 3
Completed NCT02864875 - Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial Phase 4
Completed NCT04201860 - Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds
Recruiting NCT04645199 - National Longitudinal Cohort of Hematological Diseases
Completed NCT05214300 - Screening for Bleeding Disorders in Children
Active, not recruiting NCT04188171 - Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorders Phase 2/Phase 3